Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M105011200 on June 18, 2001

J. Biol. Chem., Vol. 276, Issue 33, 30885-30891, August 17, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/33/30885    most recent
M105011200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamazaki, H.
Right arrow Articles by Guengerich, F. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamazaki, H.
Right arrow Articles by Guengerich, F. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Stimulation of Cytochrome P450 Reactions by Apo-cytochrome b5
EVIDENCE AGAINST TRANSFER OF HEME FROM CYTOCHROME P450 3A4 TO APO-CYTOCHROME b5 OR HEME OXYGENASE*

Hiroshi YamazakiDagger , Tsutomu Shimada§, Martha V. Martin, and F. Peter Guengerich||

From the Dagger  Division of Drug Metabolism, Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa 920-0934, Japan, the § Osaka Prefectural Institute of Public Health, Osaka 537-0025, Japan, and the  Department of Biochemistry and Center in Molecular Toxicology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146

Many cytochrome P450 (P450)-dependent reactions have been shown to be stimulated by another microsomal protein, cytochrome b5 (b5). Two major explanations are (i) direct electron transfer from b5 and (ii) a conformational effect in the absence of electron transfer. Some P450s (e.g. 3A4, 2C9, 17A, and 4A7) are stimulated by either b5 or b5 devoid of heme (apo-b5), indicating a lack of electron transfer, whereas other P450s (e.g. 2E1) are stimulated by b5 but not by apo-b5. Recently, a proposal has been made by Guryev et al. (Biochemistry 40, 5018-5031, 2001) that the stimulation by apo-b5 can be explained only by transfer of heme from P450 preparations to apo-b5, enabling electron transfer. We have repeated earlier findings of stimulation of catalytic activity of testosterone 6beta -hydroxylation activities with four P450 preparations, in which nearly all of the heme was accounted for as P450. Spectral analysis of mixtures indicated that only ~5% of the heme can be transferred to apo-b5, which cannot account for the observed stimulation. The presence of the heme scavenger apomyoglobin did not inhibit the stimulation of P450 3A4-dependent testosterone or nifedipine oxidation activity. Further evidence against the presence of loosely bound P450 3A4 heme was provided in experiments with apo-heme oxygenase, in which only 3% of the P450 heme was converted to biliverdin. Finally, b5 supported NADH-b5 reductase/P450 3A4-dependent testosterone 6beta -hydroxylation, but apo-b5 did not. Thus, apo-b5 can stimulate P450 3A4 reactions as well as b5 in the absence of electron transfer, and heme transfer from P450 3A4 to apo-b5 cannot be used to explain the catalytic stimulation.


* This research was supported in part by United States Public Health Service Grants R35 CA44353, R01 CA90426, and P30 ES00267 and grants from the Ministry of Education, Science, and Culture of Japan and the Ministry of Health and Welfare of Japan.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: Dept. of Biochemistry and Center in Molecular Toxicology, Vanderbilt University School of Medicine, 638 Robinson Research Building (MRBI), 23rd and Pierce Avenues, Nashville, TN 37232-0146. Tel.: 615-322-2261; Fax: 615-322-3141; E-mail: guengerich@toxicology.mc.vanderbilt.edu.


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. D. Finn, L. A. McLaughlin, S. Ronseaux, I. Rosewell, J. B. Houston, C. J. Henderson, and C. R. Wolf
Defining the in Vivo Role for Cytochrome b5 in Cytochrome P450 Function through the Conditional Hepatic Deletion of Microsomal Cytochrome b5
J. Biol. Chem., November 14, 2008; 283(46): 31385 - 31393.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
N. N. Bumpus and P. F. Hollenberg
Investigation of the Mechanisms Underlying the Differential Effects of the K262R Mutation of P450 2B6 on Catalytic Activity
Mol. Pharmacol., October 1, 2008; 74(4): 990 - 999.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
C. W. Locuson, L. C. Wienkers, J. P. Jones, and T. S. Tracy
CYP2C9 Protein Interactions with Cytochrome b5: Effects on the Coupling of Catalysis
Drug Metab. Dispos., July 1, 2007; 35(7): 1174 - 1181.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Gao, C. E. Doneanu, S. A. Shaffer, E. T. Adman, D. R. Goodlett, and S. D. Nelson
Identification of the Interactions between Cytochrome P450 2E1 and Cytochrome b5 by Mass Spectrometry and Site-directed Mutagenesis
J. Biol. Chem., July 21, 2006; 281(29): 20404 - 20417.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
M. A. Hummel, T. S. Tracy, J. M. Hutzler, J. L. Wahlstrom, Y. Zhou, and D. A. Rock
Influence of Fluorescent Probe Size and Cytochrome b5 on Drug-Drug Interactions in CYP2C9
J Biomol Screen, April 1, 2006; 11(3): 303 - 309.
[Abstract] [PDF]


Home page
Drug Metab. Dispos.Home page
S. Kumar, D. R. Davydov, and J. R. Halpert
ROLE OF CYTOCHROME B5 IN MODULATING PEROXIDE-SUPPORTED CYP3A4 ACTIVITY: EVIDENCE FOR A CONFORMATIONAL TRANSITION AND CYTOCHROME P450 HETEROGENEITY
Drug Metab. Dispos., August 1, 2005; 33(8): 1131 - 1136.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. V. Pandey and W. L. Miller
Regulation of 17,20 Lyase Activity by Cytochrome b5 and by Serine Phosphorylation of P450c17
J. Biol. Chem., April 8, 2005; 280(14): 13265 - 13271.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
M. P. Duarte, B. B. Palma, A. A. Gilep, A. Laires, J. S. Oliveira, S. A. Usanov, J. Rueff, and M. Kranendonk
The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450 mediated biotransformation
Mutagenesis, March 1, 2005; 20(2): 93 - 100.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
Y. Yamaguchi, K. K. Khan, Y. A. He, Y. Q. He, and J. R. Halpert
TOPOLOGICAL CHANGES IN THE CYP3A4 ACTIVE SITE PROBED WITH PHENYLDIAZENE: EFFECT OF INTERACTION WITH NADPH-CYTOCHROME P450 REDUCTASE AND CYTOCHROME B5 AND OF SITE-DIRECTED MUTAGENESIS
Drug Metab. Dispos., January 1, 2004; 32(1): 155 - 161.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Stiborova, V. Martinek, H. Rydlova, P. Hodek, and E. Frei
Sudan I Is a Potential Carcinogen for Humans: Evidence for Its Metabolic Activation and Detoxication by Human Recombinant Cytochrome P450 1A1 and Liver Microsomes
Cancer Res., October 15, 2002; 62(20): 5678 - 5684.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. H. Hanna, J. A. Krauser, H. Cai, M.-S. Kim, and F. P. Guengerich
Diversity in Mechanisms of Substrate Oxidation by Cytochrome P450 2D6. LACK OF AN ALLOSTERIC ROLE OF NADPH-CYTOCHROME P450 REDUCTASE IN CATALYTIC REGIOSELECTIVITY
J. Biol. Chem., October 19, 2001; 276(43): 39553 - 39561.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement